| Literature DB >> 28894598 |
Hui Ying Ang1, Ying Ying Huang2, Soo Teik Lim1,3, Philip Wong1,3, Michael Joner4, Nicolas Foin1.
Abstract
Bioresorbable scaffolds (BRS) were developed to overcome the drawbacks of current metallic drug-eluting stents (DES), such as late in-stent restenosis and caging of the vessel permanently. The concept of the BRS is to provide transient support to the vessel during healing before being degraded and resorbed by the body, freeing the vessel and restoring vasomotion. The mechanical properties of the BRS are influenced by the choice of the material and processing methods. Due to insufficient radial strength of the bioresorbable material, BRS often required large strut profile as compared to conventional metallic DES. Having thick struts will in turn affect the deliverability of the device and may cause flow disturbance, thereby increasing the incidence of acute thrombotic events. Currently, the bioresorbable poly-l-lactic acid (PLLA) polymer and magnesium (Mg) alloys are being investigated as materials in BRS technologies. The bioresorption process, mechanical properties, in vitro observations and clinical outcomes of PLLA-based and Mg-based BRS will be examined in this review.Entities:
Keywords: Bioresorbable stents; bioresorbable scaffolds (BRS); bioresorbable vascular scaffold (BVS); coronary artery disease; coronary stents; magnesium (Mg) stents
Year: 2017 PMID: 28894598 PMCID: PMC5583085 DOI: 10.21037/jtd.2017.06.30
Source DB: PubMed Journal: J Thorac Dis ISSN: 2072-1439 Impact factor: 2.895